SPC
RETA

Sigma Planning Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Sigma Planning Corp’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$385K Sell
2023
Q1 		$575K Sell
2022
Q4 		$353K Sell
2022
Q3 		$236K Sell
2022
Q2 		$313K Buy
2021
Q4 		– Sell
2021
Q3 		$658K Buy
2021
Q2 		$900K Buy
2021
Q1 		$433K Buy
2020
Q4 		$459K Buy